Matches in SemOpenAlex for { <https://semopenalex.org/work/W2124805020> ?p ?o ?g. }
Showing items 1 to 54 of
54
with 100 items per page.
- W2124805020 abstract "Resume Cet article discute du cas d’un patient, M. D., âge de 60 ans qui est atteint de leucemie myeloide aigue (type M3) depuis 1995 et pour laquelle il a deja recu plusieurs traitements de chimiotherapie incluant la daunorubicine, la cytarabine et l’acide tout-trans retinoique (ATRA). Le patient a fait une premiere rechute en 1998, puis une seconde en mars 2001 alors qu’il recevait l’ATRA a une dose de 40 mg deux fois par jour de facon cyclique (2 semaines sur 6) et 15 mg per os de methotrexate 1 fois par semaine. A la suite de cette seconde rechute sous l’ATRA, le patient a ete admis a l’unite d’hematologie pour une neutropenie. L’equipe traitante a decide de debuter un traitement avec l’arsenic. Ce dernier medicament a ete debute en mai 2001 a une dose de 10 mg une fois par jour par voie intraveineuse. Abstract Prevention and management of osteoporosis This article discusses the case of a 60-year-old patient suffering from acute promyelocytic leukemia since 1995 for which he received multiple chemotherapy treatments including daunorubicine, cytarabine and all-trans retinoic acid (ATRA). The patient had his first relapse in 1998 and a second in March 2001 while he was receiving ATRA at 40 mg twice a day (2 weeks of 6) and 15 mg of methotrexate once a week. Following the second relapse, the patient was admitted to the hematology unit for neutropenia. The medical team decided to start at that point an arsenic trioxide treatment. The medication was started in May 2001 with an intravenous dose of 10 mg once daily. Furthermore, the article reviews the place of arsenic trioxide in the current management of the acute promyelocytic leukemia patients." @default.
- W2124805020 created "2016-06-24" @default.
- W2124805020 creator A5014367895 @default.
- W2124805020 date "2001-01-01" @default.
- W2124805020 modified "2023-09-27" @default.
- W2124805020 title "L’arsenic, un agent toxique? Utilisation de l’arsenic dans le traitement des leucémies myéloïdes aiguës de type M3" @default.
- W2124805020 cites W109021107 @default.
- W2124805020 cites W1515269506 @default.
- W2124805020 cites W1981640544 @default.
- W2124805020 cites W2013051826 @default.
- W2124805020 cites W2025373117 @default.
- W2124805020 cites W2046434962 @default.
- W2124805020 cites W2072103198 @default.
- W2124805020 cites W2095357364 @default.
- W2124805020 cites W2108286676 @default.
- W2124805020 cites W2122906481 @default.
- W2124805020 cites W2128291738 @default.
- W2124805020 cites W2142423276 @default.
- W2124805020 cites W2145492248 @default.
- W2124805020 cites W2157984536 @default.
- W2124805020 cites W2184391500 @default.
- W2124805020 cites W2314037093 @default.
- W2124805020 cites W2333481337 @default.
- W2124805020 cites W2334200141 @default.
- W2124805020 cites W2396425822 @default.
- W2124805020 hasPublicationYear "2001" @default.
- W2124805020 type Work @default.
- W2124805020 sameAs 2124805020 @default.
- W2124805020 citedByCount "0" @default.
- W2124805020 crossrefType "journal-article" @default.
- W2124805020 hasAuthorship W2124805020A5014367895 @default.
- W2124805020 hasConcept C104317684 @default.
- W2124805020 hasConcept C185592680 @default.
- W2124805020 hasConcept C2776601000 @default.
- W2124805020 hasConcept C2781121885 @default.
- W2124805020 hasConcept C29456083 @default.
- W2124805020 hasConcept C55493867 @default.
- W2124805020 hasConcept C71924100 @default.
- W2124805020 hasConceptScore W2124805020C104317684 @default.
- W2124805020 hasConceptScore W2124805020C185592680 @default.
- W2124805020 hasConceptScore W2124805020C2776601000 @default.
- W2124805020 hasConceptScore W2124805020C2781121885 @default.
- W2124805020 hasConceptScore W2124805020C29456083 @default.
- W2124805020 hasConceptScore W2124805020C55493867 @default.
- W2124805020 hasConceptScore W2124805020C71924100 @default.
- W2124805020 hasIssue "5" @default.
- W2124805020 hasLocation W21248050201 @default.
- W2124805020 hasOpenAccess W2124805020 @default.
- W2124805020 hasPrimaryLocation W21248050201 @default.
- W2124805020 hasVolume "34" @default.
- W2124805020 isParatext "false" @default.
- W2124805020 isRetracted "false" @default.
- W2124805020 magId "2124805020" @default.
- W2124805020 workType "article" @default.